RS59232B1 - Postupci za uklanjanje zagađivača koristeći hromatografiju membrane razmene jona sa razmeštanjem autohtonih proteina - Google Patents

Postupci za uklanjanje zagađivača koristeći hromatografiju membrane razmene jona sa razmeštanjem autohtonih proteina

Info

Publication number
RS59232B1
RS59232B1 RSP20191119A RS59232B1 RS 59232 B1 RS59232 B1 RS 59232B1 RS P20191119 A RSP20191119 A RS P20191119A RS 59232 B1 RS59232 B1 RS 59232B1
Authority
RS
Serbia
Prior art keywords
contaminant
methods
ion exchange
exchange membrane
membrane chromatography
Prior art date
Application number
Other languages
English (en)
Inventor
Arick Brown
Jerome Bill Jr
Timothy Tully
Christopher Dowd
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39899038&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS59232(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of RS59232B1 publication Critical patent/RS59232B1/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
RSP20191119 2008-08-14 2008-08-14 Postupci za uklanjanje zagađivača koristeći hromatografiju membrane razmene jona sa razmeštanjem autohtonih proteina RS59232B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14189582.1A EP2848625B1 (en) 2008-08-14 2008-08-14 Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography
PCT/US2008/073179 WO2010019148A1 (en) 2008-08-14 2008-08-14 Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography

Publications (1)

Publication Number Publication Date
RS59232B1 true RS59232B1 (sr) 2019-10-31

Family

ID=39899038

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP20191119 RS59232B1 (sr) 2008-08-14 2008-08-14 Postupci za uklanjanje zagađivača koristeći hromatografiju membrane razmene jona sa razmeštanjem autohtonih proteina

Country Status (23)

Country Link
US (2) US10927144B2 (sr)
EP (3) EP2848625B1 (sr)
JP (1) JP5666447B2 (sr)
KR (3) KR102196883B1 (sr)
CN (1) CN102149724B (sr)
AU (1) AU2008360625C1 (sr)
BR (1) BRPI0823046B1 (sr)
CA (1) CA2731943C (sr)
CY (1) CY1122221T1 (sr)
DK (2) DK3604324T3 (sr)
ES (2) ES2527943T5 (sr)
FI (1) FI3604324T3 (sr)
HK (1) HK1210181A1 (sr)
HR (2) HRP20240472T1 (sr)
HU (1) HUE047316T2 (sr)
IL (2) IL210912B (sr)
LT (2) LT2848625T (sr)
MX (1) MX2011001506A (sr)
PL (2) PL2848625T3 (sr)
PT (2) PT3604324T (sr)
RS (1) RS59232B1 (sr)
SI (2) SI3604324T1 (sr)
WO (1) WO2010019148A1 (sr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101663390B (zh) 2006-09-13 2013-10-23 Abbvie公司 使用非动物源水解产物的分批补料细胞培养方法
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
MX2011001506A (es) 2008-08-14 2011-03-15 Genentech Inc Metodos para eliminar un contaminante utilizado cromatografia de membrana de intercambio de ion en desplazamiento de proteina indigena.
SG10201702922VA (en) 2008-10-20 2017-06-29 Abbvie Inc Isolation and purification of antibodies using protein a affinity chromatography
CA2738499A1 (en) * 2008-10-20 2010-04-29 Abbott Laboratories Viral inactivation during purification of antibodies
MX370828B (es) † 2010-05-25 2020-01-08 Genentech Inc Métodos de purificación de polipéptidos.
WO2012030512A1 (en) * 2010-09-03 2012-03-08 Percivia Llc. Flow-through protein purification process
US20130337528A1 (en) * 2010-12-10 2013-12-19 Tracy Thompson Compositions for separation methods
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
JP6605202B2 (ja) * 2011-12-22 2019-11-13 ジェネンテック， インコーポレイテッド イオン交換膜クロマトグラフィー
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
WO2014133458A1 (en) * 2013-02-26 2014-09-04 Agency For Science, Technology And Research Protein purification in the presence of nonionic organic polymers and electropositive surfaces
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
EP2987801B1 (en) * 2013-04-16 2019-06-12 Asahi Kasei Medical Co., Ltd. Method for the removal of aggregates from a solution containing an antibody protein
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
EP2986307A4 (en) 2014-01-03 2017-04-12 Bio-rad Laboratories, Inc. Removal of impurities from protein a eluates
AU2017323583A1 (en) * 2016-09-07 2019-03-14 Glaxosmithkline Intellectual Property Development Limited Methods for purifying antibodies
CN109689189B (zh) 2016-09-09 2022-02-01 3M创新有限公司 官能化共聚物及其使用
US10053368B1 (en) * 2017-09-07 2018-08-21 Chevron U.S.A. Inc. Synthesis of AFX framework type molecular sieves
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
TWI814812B (zh) * 2018-05-02 2023-09-11 美商里珍納龍藥品有限公司 用於評估生化過濾器的適合性的方法
EP3810650A1 (en) * 2018-06-19 2021-04-28 Bristol-Myers Squibb Company Methods of purifying proteins using chromatography
CN109324143B (zh) * 2018-10-19 2021-10-29 张骐 利用二维液相分离制备抗体类产品相关杂质的方法
CN109806916B (zh) * 2019-03-15 2021-12-21 中科森辉微球技术（苏州）有限公司 高性能阴离子交换介质及其制备方法
KR20220112014A (ko) 2021-02-03 2022-08-10 고인석 십전대보탕을 이용하여 만든 오리목뼈 간식
CN118290514A (zh) * 2024-06-05 2024-07-05 东曜药业有限公司 基于阴离子膜的抗体偶联药物的纯化方法及抗体偶联药物

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4347322A (en) † 1981-01-12 1982-08-31 Nabisco Brands, Inc. Chromatographic process for enzyme purification
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
ATE113846T1 (de) 1988-06-21 1994-11-15 Genentech Inc Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
WO1990003430A1 (en) 1988-09-23 1990-04-05 Cetus Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
CA2113813C (en) 1991-08-14 2005-04-12 Paula M. Jardieu Immunoglobulin variants for specific fc epsilon receptors
DE69233528T2 (de) 1991-11-25 2006-03-16 Enzon, Inc. Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen
ATE503496T1 (de) 1992-02-06 2011-04-15 Novartis Vaccines & Diagnostic Biosynthetisches bindeprotein für tumormarker
EP0656789B1 (en) 1992-08-21 1997-12-17 Genentech, Inc. Method for treating a lfa-1-mediated disorder
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
CA2106612C (en) † 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
ES2108566T3 (es) 1993-12-10 1997-12-16 Genentech Inc Procedimientos para diagnosticar alergias y para seleccionar agentes terapeuticos antialergicos.
MX9602818A (es) 1994-01-18 1997-06-28 Genentech Inc Un metodo de tratamiento de infeccion parasitaria usando antagonistas ige.
JP3780315B2 (ja) 1994-03-03 2006-05-31 ジェネンテク・インコーポレイテッド 炎症性疾患の処置のための抗ｉｌ−８モノクローナル抗体
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
EP0831880A4 (en) 1995-06-07 2004-12-01 Imclone Systems Inc ANTIBODIES AND FRAGMENTS OF ANTIBODIES INHIBITING TUMOR GROWTH
PT877626E (pt) 1996-01-23 2003-01-31 Univ Vermont And State Agric C Anticorpos anti-cd1s para utilizacao contra icto
AU1458497A (en) 1996-01-31 1997-08-22 John Stephen Ayers Production of an immunoglobulin enriched fraction from whey protein solutions
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
KR100532178B1 (ko) 1996-11-27 2005-12-01 제넨테크, 인크. 인간화 항-ＣＤ11ａ 항체
EP1787999B1 (en) 1997-04-07 2010-08-04 Genentech, Inc. Anti-VEGF antibodies
WO1998051793A1 (en) 1997-05-15 1998-11-19 Genentech, Inc. Apo-2 RECEPTOR
KR100960211B1 (ko) * 1998-05-06 2010-05-27 제넨테크, 인크. 이온 교환 크로마토그래피에 의한 단백질 정제 방법
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
ES2309012T3 (es) 1999-10-29 2008-12-16 Genentech, Inc. Composiciones del anticuerpo anti-psca y a sus procedimientos contra celulas cancerigenas que expresen psca.
US6479636B1 (en) † 2000-04-11 2002-11-12 Honiron Corporation (A Louisiana Corporation) Sugarcane fractioning system
US6633462B2 (en) 2000-07-13 2003-10-14 Koninklijke Philips Electronics N.V. Magnetoresistive angle sensor having several sensing elements
UA83458C2 (uk) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
GB2372464B (en) † 2001-02-22 2003-05-14 Vivascience Ltd Method of isolating a charged compound
US7321026B2 (en) 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
WO2003033658A2 (en) 2001-10-17 2003-04-24 Human Genome Sciences, Inc. Neutrokine-alpha and neutrokine-alpha splice variant
US20040093621A1 (en) 2001-12-25 2004-05-13 Kyowa Hakko Kogyo Co., Ltd Antibody composition which specifically binds to CD20
KR101033196B1 (ko) 2002-02-14 2011-05-09 이뮤노메딕스, 인코오포레이티드 항-ｃｄ20 항체 및 그 융합 단백질 및 이들의 이용방법
US7323553B2 (en) † 2002-04-26 2008-01-29 Genentech, Inc. Non-affinity purification of proteins
ES2558303T3 (es) * 2002-09-11 2016-02-03 Chugai Seiyaku Kabushiki Kaisha Método de purificación de proteínas
ATE540978T1 (de) 2002-10-17 2012-01-15 Genmab As Humane monoklonale antikörper gegen cd20
CN103833854B (zh) 2002-12-16 2017-12-12 健泰科生物技术公司 免疫球蛋白变体及其用途
EP1626993B1 (en) 2003-05-09 2015-03-11 Duke University Cd20-specific antibodies and methods of employing same
AR044388A1 (es) 2003-05-20 2005-09-07 Applied Molecular Evolution Moleculas de union a cd20
CA2534898A1 (en) 2003-08-08 2005-02-17 Immunomedics, Inc. Bispecific antibodies for inducing apoptosis of tumor and diseased cells
US8147832B2 (en) 2003-08-14 2012-04-03 Merck Patent Gmbh CD20-binding polypeptide compositions and methods
NZ547315A (sr) 2003-10-27 2008-07-31 Wyeth Corp
WO2006086586A2 (en) 2005-02-10 2006-08-17 Baylor Research Institute Anti-interferon alpha monoclonal antibodies and methods for use
JP5199063B2 (ja) 2005-03-11 2013-05-15 ワイス・エルエルシー 弱分配クロマトグラフィー方法
JP2009530378A (ja) † 2006-03-20 2009-08-27 メダレックス インコーポレーティッド タンパク質精製法
US20100075375A1 (en) 2006-10-03 2010-03-25 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
WO2009135656A1 (en) 2008-05-06 2009-11-12 Lonza Biologics Plc. A method for the purification of antibodies using displacement chromatography
MX2011001506A (es) 2008-08-14 2011-03-15 Genentech Inc Metodos para eliminar un contaminante utilizado cromatografia de membrana de intercambio de ion en desplazamiento de proteina indigena.
US9813410B2 (en) 2014-06-26 2017-11-07 Rakuten, Inc. Information processing apparatus, information processing method, and information processing program

Also Published As

Publication number Publication date
IL262657A (en) 2018-12-31
KR20110067099A (ko) 2011-06-21
US10927144B2 (en) 2021-02-23
MX2011001506A (es) 2011-03-15
BRPI0823046B1 (pt) 2021-12-14
ES2527943T3 (es) 2015-02-02
PT3604324T (pt) 2024-05-10
EP3604324A1 (en) 2020-02-05
KR102196883B1 (ko) 2020-12-30
AU2008360625B2 (en) 2016-05-19
EP2321337B2 (en) 2018-10-10
US20210284685A1 (en) 2021-09-16
HK1210181A1 (en) 2016-04-15
ES2749190T3 (es) 2020-03-19
PL2848625T3 (pl) 2020-01-31
BRPI0823046A2 (pt) 2015-07-28
DK3604324T3 (da) 2024-04-08
IL210912B (en) 2019-03-31
EP2848625B1 (en) 2019-07-31
HUE047316T2 (hu) 2020-04-28
CN102149724B (zh) 2014-04-09
EP2321337B1 (en) 2014-10-22
KR20180033311A (ko) 2018-04-02
EP3604324B1 (en) 2024-02-28
EP2848625A1 (en) 2015-03-18
CA2731943A1 (en) 2010-02-18
LT2848625T (lt) 2019-10-10
PL3604324T3 (pl) 2024-07-01
AU2008360625C1 (en) 2017-01-19
LT3604324T (lt) 2024-05-10
KR101843915B1 (ko) 2018-04-02
IL210912A0 (en) 2011-04-28
HRP20240472T1 (hr) 2024-06-21
HRP20191848T1 (hr) 2019-12-27
AU2008360625A1 (en) 2010-02-18
IL262657B (en) 2021-03-25
US20120122759A1 (en) 2012-05-17
ES2527943T5 (es) 2019-03-07
PT2848625T (pt) 2019-10-25
EP2321337A1 (en) 2011-05-18
KR20180137591A (ko) 2018-12-27
JP2011530592A (ja) 2011-12-22
CA2731943C (en) 2016-11-29
SI3604324T1 (sl) 2024-06-28
WO2010019148A1 (en) 2010-02-18
EP2321337B9 (en) 2016-11-30
FI3604324T3 (fi) 2024-05-16
CY1122221T1 (el) 2020-11-25
DK2848625T3 (da) 2019-10-07
JP5666447B2 (ja) 2015-02-12
SI2848625T1 (sl) 2019-11-29
CN102149724A (zh) 2011-08-10

Similar Documents

Publication Publication Date Title
IL262657B (en) Methods for removing a contaminant using natural protein transfer in ion exchange membrane chromatography
ZA201002497B (en) Method for making contact lenses
EP2197562A4 (en) LIQUID SEPARATION THROUGH MEMBRANE-BASED STEAM PROCESS
EP2160227A4 (en) chromatographic methods
IL211217A0 (en) Methods for evaluating chromatography column performance
GB0619534D0 (en) Recap alignment clamp
EP2313172A4 (en) BLOCK CONFIGURATION FOR DISTILLATION ON LARGE SCALE MEMBRANE
GB2462516B (en) Methods for operating a filtration system
RS56857B1 (sr) Postupak za odvajanje betaina
IL205107A0 (en) Method for purifying fc-fusion proteins
EP2263105A4 (en) METHOD FOR PERFORMING STRAINED POLARIZATION FILTRATION
EP2170479A4 (en) RECOVERY PROCESS
FR2911793B1 (fr) Procede de separation par chromatographie
EP1987874A4 (en) PROCESS FOR PRODUCING A SEPARATION MEMBRANE BASED ON ZEOLITE
EP2235521A4 (en) METHOD FOR REMOVING AIR FROM A CHROMATOGRAPHIC COLUMN
PL2650302T3 (pl) Sposób usuwania endotoksyny z białek
EP1979927A4 (en) REDEPOSITION TECHNIQUE FOR MEMBRANE FIXATION
EP2213747A4 (en) METHOD FOR PRODUCING A MEMBRANE PROTEIN
PL2257537T3 (pl) Sposób oczyszczania epichlorohydryn
EP2322498A4 (en) PROCESS FOR REMOVING DIBENO FUELS
EP2216408A4 (en) METHOD FOR IMPROVING SALINITY TOLERANCE
EP2005930A4 (de) Verfahren zur faltenentfernung
PL2134498T3 (pl) Sposób dla procesów autogenicznych
EP2129451A4 (en) METHOD FOR REMOVING STYRENE
FI20065014A (fi) Menetelmä betaiinin erottamiseksi